Efficacy and Durability of Immune Response after Receipt of HPV Vaccines in People Living with HIV

People living with HIV (PLH) experience higher rates of HPV infection as well as an increased risk of HPV-related disease, including malignancies. Although they are considered a high-priority group for HPV vaccination, there are limited data regarding the long-term immunogenicity and efficacy of HPV...

Descripción completa

Detalles Bibliográficos
Autores principales: Losada, Cecilia, Samaha, Hady, Scherer, Erin M., Kazzi, Bahaa, Khalil, Lana, Ofotokun, Ighovwerha, Rouphael, Nadine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301114/
https://www.ncbi.nlm.nih.gov/pubmed/37376456
http://dx.doi.org/10.3390/vaccines11061067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301114/
https://www.ncbi.nlm.nih.gov/pubmed/37376456
http://dx.doi.org/10.3390/vaccines11061067

Ejemplares similares